Phoenix Biotechnology Obtains $852,000 New Round

  • Feed Type
  • Date
    6/18/2014
  • Company Name
    Phoenix Biotechnology
  • Mailing Address
    8626 Tesoro Dr. San Antonio, TX 78217 USA
  • Company Description
    The company was created through the acquisition of the assets of Anvirlat, Inc., a privately held Nevada corporation controlled by Messrs. Addington and Kost, current officers and directors of the company.
  • Website
    http://www.phoenixbiotechnology.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $852,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy